Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
WAYNE, Pa., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for ... Biopharmaceuticals, Reimbursement Egalet Corp, SPRIX , ketorolac tromethamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 13, 2018 Category: Drugs & Pharmacology Source Type: news

Toradol (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular (Ketorolac Tromethamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acular LS (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Acuvail (Ketorolac Tromethamine Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Sprix (Ketorolac Tromethamine Nasal Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 9, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection (Updated - Resolved)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 23, 2016 Category: Drugs & Pharmacology Source Type: news

Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials
Administration of particulates has the potential for localized inflammation, allergic reaction, granuloma formation, microembolic effects, or delay of therapy. (Source: FDA MedWatch)
Source: FDA MedWatch - February 11, 2015 Category: American Health Source Type: news

Ketorolac Tromethamine Injection by Sagent Pharmaceuticals Recalled:...
On October 6, the FDA announced that three lots of Ketorolac Tromethamine Injection, USP, 30mg/mL single-dose vials, distributed by Sagent, are recalled due to incorrect labeling. In light of this...(PRWeb October 09, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12235068.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 9, 2014 Category: Pharmaceuticals Source Type: news

Ketorolac Tromethamine Injection, USP, 30mg/ml by Sagent Pharmaceuticals: Recall - Incorrect Labeling
The labeled expiration date is longer than the known stability of the product. (Source: FDA MedWatch)
Source: FDA MedWatch - October 6, 2014 Category: American Health Source Type: news